Entera Bio (ENTX) Gross Margin Growth (1y) (2020 - 2022)

Entera Bio (ENTX) Gross Margin Growth (1y) (2020 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 372.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -165.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Entera Bio 186.78 Mn 182.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 2,528.00
Sep 30, 2022 -2,857.00
Jun 30, 2022 1,583.00
Mar 31, 2022 -3,291.00
Jun 30, 2021 -3,121.00
Jun 30, 2020 2,417.00